Medlab Clinical Ltd. announced, pursuant to the Pharmacare Australian nutraceutical deal announced in November 2021, Medlab has invoiced $275K (incl. GST) to PharmaCare for the first royalty cheque. Proceeds expected second week of December 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% |
|
-5.04% | -.--% |
05-15 | Medlab Clinical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
04-24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 10.01M | |
+16.02% | 122B | |
+18.96% | 113B | |
+18.95% | 26.49B | |
-23.44% | 19.4B | |
-19.03% | 16.24B | |
-20.04% | 15.4B | |
-46.14% | 15.15B | |
+64.61% | 14.93B | |
+4.65% | 13.52B |
- Stock Market
- Equities
- MDC Stock
- News Medlab Clinical Limited
- Medlab Clinical Limited Invoices First Royalty Cheque to PharmaCare